Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people notice itching after starting semaglutide — at the injection site, across the skin more broadly, or as part of an allergic response. It's one of the less-talked-about reactions, but it does happen, and knowing what's likely harmless versus what needs prompt attention makes a real difference. Semaglutide (sold for weight management as Wegovy) is a prescription-only medicine; a prescriber assesses your full health picture before it's dispensed, and any skin changes are worth raising with your clinical team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scenario: it's a day or two after your weekly injection, and the skin around the site is red, raised, and irritating. This is the most common pattern. Localised injection-site reactions (itching, redness, a small lump) are listed among the known side effects of semaglutide in both the NHS patient information on semaglutide and the medicine's Summary of Product Characteristics. The body's mast cells respond to a foreign substance entering the skin, releasing histamine, and that creates the itch. For most people it fades within 24 to 48 hours.
Rotating your injection sites helps. Abdomen, outer thigh, and upper arm are all suitable; using the same spot repeatedly concentrates the local reaction and prolongs it. Letting the pen reach room temperature before injecting, and going slowly, can also reduce the sharp histamine spike at the site. If the redness spreads significantly beyond the injection area, or the lump is hard and growing after 48 hours, contact your prescriber, it's not an emergency in most cases, but it warrants a clinical look rather than waiting it out.
A question our prescribers hear most weeks is whether over-the-counter antihistamines or a cool compress can help, and our dedicated guide to semaglutide side effects and itchy skin goes into this in more detail. Both are reasonable for a mild site reaction; your prescriber or pharmacist can confirm what's appropriate for you personally, since some antihistamines interact with other medicines.
Generalised itching (spread across the torso, arms, or scalp) is less common but reported. It can emerge as the dose increases, when the body is adjusting to a higher level of the drug. This pattern tends to track with the escalation schedule: it appears in the days after moving up a dose and then eases. If it's mild and you're otherwise well, it's worth logging it and mentioning it at your next clinical check-in. That said, don't dismiss itching that comes with a rash covering a large area of skin.
Urticaria (hives) is a more significant signal. If raised, blotchy welts appear across the body alongside itching, that picture starts to look like a hypersensitivity response rather than simple adjustment. The full side-effect profile for Wegovy covers this in more detail, but the practical rule is straightforward: hives plus any facial swelling, lip or tongue swelling, difficulty swallowing, or a tight feeling in the chest means stopping the injection, calling 999, and telling the operator you may be having an allergic reaction to a medicine. Anaphylaxis is rare with semaglutide, but rare is not the same as impossible.
For milder widespread itching with no hives or swelling, our overview of side effects from semaglutide can help you understand what to expect before you contact your prescribing service the same day. They may ask you to pause the next dose while they assess.
This is the part most online searches miss. Semaglutide slows gastric emptying, which can alter the flow of bile and increase the risk of gallstones in some people. Gallbladder disease is a recognised side effect listed in the medicine's prescribing information. Persistent itching (particularly on the palms or soles, or across the body without a rash) combined with pale stools, dark urine, or a yellowing of the skin or the whites of the eyes points toward a liver or bile duct issue rather than a skin reaction. These symptoms need same-day GP contact or an urgent walk-in assessment; they are not a "wait and see" situation.
Upper-right abdominal pain that is severe or that radiates through to the back also needs prompt assessment. The MHRA's Drug Safety Update communications on GLP-1 medicines include guidance on pancreatitis (a different condition, but one that shares some abdominal symptoms) and the overall message from regulators is consistent: persistent stomach or back pain on these medicines should be checked out the same day, not managed at home. Our broader guide to semaglutide side effects covers the pancreatitis warning in full.
If itching or any other unexpected change concerns you, the MHRA's Yellow Card reporting scheme lets patients (not just healthcare professionals) submit suspected side effects directly. You can do this alongside, not instead of, contacting your prescriber. Both matter: your prescriber can adjust your treatment; Yellow Card reports shape future safety guidance for everyone taking the medicine.
Patients who started treatment through a regulated online service often ask who to contact if something happens between doses. At nume, aftercare is available seven days a week, you don't have to wait until a Monday morning to raise a skin reaction. Our contact page has details. If you're still weighing up whether semaglutide is suitable for you, our prescribers discuss side effects (including skin reactions) as part of every consultation, so nothing catches you off guard. Start your free consultation to speak with a clinician about your specific situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.